<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38140174</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>27</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity-ORCHESTRA Project.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1769</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines11121769</ELocationID><Abstract><AbstractText><b>Introduction:</b> The impact of long-COVID-19 syndrome is rather variable, since it is influenced by several residual confounders. This study aimed to investigate the prevalence of long COVID-19 in healthcare workers (HCWs) from four university hospitals in north-eastern Italy: Trieste, Padua, Verona, and Modena-Reggio Emilia. <b>Methods:</b> During the period June 2022-August 2022, HCWs were surveyed for past COVID-19 infections, medical history, and any acute as well as post-COVID-19 symptoms. The prevalence of long COVID-19 was estimated at 30-60 days or 61+ days since first negative swab following first and second COVID-19 episode. Furthermore, the risk of long COVID-19 was investigated by multivariable logistic regression. Results were expressed as the adjusted odds ratio (aOR) with a 95% confidence interval (95%CI). <b>Results:</b> 5432 HCWs returned a usable questionnaire: 2401 were infected with SARS-CoV-2 at least once, 230 were infected at least twice, and 8 were infected three times. The prevalence of long COVID-19 after a primary COVID-19 infection was 24.0% at 30-60 days versus 16.3% at 61+ days, and 10.5% against 5.5% after the second SARS-CoV-2 event. The most frequent symptoms after a first COVID-19 event were asthenia (30.3%), followed by myalgia (13.7%), cough (12.4%), dyspnea (10.2%), concentration deficit (8.1%), headache (7.3%), and anosmia (6.5%), in decreasing order of prevalence. The risk of long COVID-19 at 30-60 days was significantly higher in HCWs hospitalized for COVID-19 (aOR = 3.34; 95%CI: 1.62; 6.89), those infected with SARS-CoV-2 during the early pandemic waves-namely the Wuhan (aOR = 2.16; 95%CI: 1.14; 4.09) or Alpha (aOR= 2.05; 95%CI: 1.25; 3.38) transmission periods-and progressively increasing with viral shedding time (VST), especially 15+ days (aOR = 3.20; 95%CI: 2.07; 4.94). Further determinants of long COVID-19 at 30-60 days since primary COVID-19 event were female sex (aOR = 1.91; 95%CI: 1.30; 2.80), age &gt;40 years, abnormal BMI, or administrative services (reference category). In contrast, HCWs vaccinated with two doses before their primary infection (aOR = 0.57; 95%CI: 0.34; 0.94), undergraduate students, or postgraduate medical trainees were less likely to experience long COVID-19 at 30-60 days. Apart from pandemic waves, the main determinants of long COVID-19 at 30-60 days were confirmed at 61+ days. <b>Conclusions:</b> The risk of long COVID-19 following primary infection increased with the severity of acute disease and VST, especially during the initial pandemic waves, when more virulent viral strains were circulating, and susceptibility to SARS-CoV-2 was higher since most HCWs had not been infected yet, COVID-19 vaccines were still not available, and/or vaccination coverage was still building up. The risk of long COVID-19 therefore decreased inversely with humoral immunity at the individual level. Nevertheless, the prevalence of long COVID-19 was remarkably lower after SARS-CoV-2 reinfections regardless of vaccination status, suggesting that hybrid humoral immunity did not increase protection against the syndrome compared to immunity mounted by either natural infection or vaccination separately. Since the risk of long COVID-19 is currently low with Omicron and patients who developed the syndrome following SARS-CoV-2 infection in the early pandemic waves tend to return to a state of full health with time, a cost-effective approach to screen post-COVID-19 symptoms during the Omicron time could be restricted to vulnerable individuals developing severe disease and/or with prolonged VST.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cegolon</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6285-7355</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Occupational Medicine Unit, University Health Agency Giuliano-Isontina (ASUGI), 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauro</LastName><ForeName>Marcella</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1317-3448</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Occupational Medicine Unit, University Health Agency Giuliano-Isontina (ASUGI), 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sansone</LastName><ForeName>Donatella</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tassinari</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gobba</LastName><ForeName>Fabrizio Maria</ForeName><Initials>FM</Initials><Identifier Source="ORCID">0000-0002-1267-1632</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neurological Sciences, University of Modena and Reggio-Emilia, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modenese</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0850-5615</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neurological Sciences, University of Modena and Reggio-Emilia, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casolari</LastName><ForeName>Loretta</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Health Surveillance Service, Modena University Hospital, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liviero</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4497-9287</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Padua University Hospital, 35128 Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, 35128 Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavanello</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5229-9900</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Padua University Hospital, 35128 Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, 35128 Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scapellato</LastName><ForeName>Maria Luisa</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0003-4740-4865</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Padua University Hospital, 35128 Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, 35128 Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taus</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4728-6686</Identifier><AffiliationInfo><Affiliation>Department of Diagnostics and Public Health, Section of Medical Statistics, University of Verona, 37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carta</LastName><ForeName>Angela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3620-8765</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Verona University Hospital, 37134 Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diagnostics and Public Health, Section of Occupational Medicine, University of Verona, 37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiteri</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8536-7095</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Verona University Hospital, 37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Maria Grazia Lourdes</ForeName><Initials>MGL</Initials><Identifier Source="ORCID">0000-0003-4951-2528</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Verona University Hospital, 37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porru</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3564-7202</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Verona University Hospital, 37134 Verona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diagnostics and Public Health, Section of Occupational Medicine, University of Verona, 37134 Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larese Filon</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7717-0417</Identifier><AffiliationInfo><Affiliation>Occupational Medicine Unit, Department of Medical, Surgical &amp; Health Sciences, University of Trieste, 34129 Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Occupational Medicine Unit, University Health Agency Giuliano-Isontina (ASUGI), 34129 Trieste, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>101016167</GrantID><Agency>European Union</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">asthenia</Keyword><Keyword MajorTopicYN="N">disease severity</Keyword><Keyword MajorTopicYN="N">humoral immunity</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">pandemic waves</Keyword><Keyword MajorTopicYN="N">post-infective symptoms</Keyword><Keyword MajorTopicYN="N">viral shedding time</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation the data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38140174</ArticleId><ArticleId IdType="pmc">PMC10747427</ArticleId><ArticleId IdType="doi">10.3390/vaccines11121769</ArticleId><ArticleId IdType="pii">vaccines11121769</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garner P. BMJ Opinion. Paul Garner: For 7 weeks I have Been through a Roller Coaster of Ill Health, Extreme Emotions, and Utter Exhaustion. 2020.  [(accessed on 5 November 2022)].  Available online:  https://blogs.bmj.com/bmj/2020/05/05/paul-garner-peoplewho-have-a-more-protracted-illness-need-help-to-understand-andcope-with-the-constantly-shifting-bizarre-symptoms/</Citation></Reference><Reference><Citation>Perego E., Callard F., Stras L., Melville-J&#xf3;hannesson B., Pope R., Alwan N.A. Why the patient-made term &#x2018;long covid&#x2019; is needed. Wellcome Open Res. 2020;5:224. doi: 10.12688/wellcomeopenres.16307.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16307.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Yongu W.T. A Critical Review of Levels of Disease Development and Prevention in Epidemiology.  [(accessed on 5 November 2022)];Int. J. Hum. Kinet. Health Educ. 2022 6 Available online:  https://journals.aphriapub.com/index.php/IJoHKHE/article/view/1490.</Citation></Reference><Reference><Citation>Shukla A.K., Atal S., Banerjee A., Jhaj R., Balakrishnan S., Chugh P.K., Xavier D., Faruqui A., Singh A., Raveendran R., et al. An observational multi-centric COVID-19 sequelae study among health care workers. Lancet Reg. Health Southeast. Asia. 2023;10:100129. doi: 10.1016/j.lansea.2022.100129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lansea.2022.100129</ArticleId><ArticleId IdType="pmc">PMC9744681</ArticleId><ArticleId IdType="pubmed">36531928</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus.  [(accessed on 5 November 2022)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition2021.1.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE)  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 5 November 2022)].  Available online:  https://www.nice.org.uk/guidance/NG188.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)  Post-COVID Conditions: Overview for Healthcare Providers.  [(accessed on 5 November 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html#.</Citation></Reference><Reference><Citation>US Department of Health &amp; Human Services  Guidance on &#x201c;Long COVID&#x201d; as a Disability under the ADA, Section 504, and Section 1557.  [(accessed on 23 October 2023)];2021  Available online:  https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid19/guidance-long-covid-disabil-dity/index.html.</Citation></Reference><Reference><Citation>Haslam A., Olivier T., Prasad V. The definition of long COVID used in interventional studies. Eur. J. Clin. Investig. 2023;53:e13989. doi: 10.1111/eci.13989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13989</ArticleId><ArticleId IdType="pubmed">36964995</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M., Carey C., Ziauddeen N., Thomas R., Akrami A., Lutje V., Greenwood D.C., Alwan N.A. Systematic Review of the Prevalence of Long COVID. Open Forum Infect. Dis. 2023;10:ofad233. doi: 10.1093/ofid/ofad233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorettu L., Mastrangelo G., Stepien J., Grabowski J., Meloni R., Piu D., Michalski T., Waszak P.M., Bellizzi S., Cegolon L. Attitudes and Perceptions of Health Protection Measures Against the Spread of COVID-19 in Italy and Poland. Front. Psychol. 2021;12:805790. doi: 10.3389/fpsyg.2021.805790.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.805790</ArticleId><ArticleId IdType="pmc">PMC8754188</ArticleId><ArticleId IdType="pubmed">35035377</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1944. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc H.C., Xiao J., Liu W., Li Y., Chen G. Long COVID and its Management. Int. J. Biol. Sci. 2022;18:4768&#x2013;4780. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone D., Tassinari A., Valentinotti R., Kontogiannis D., Ronchese F., Centonze S., Maggiore A., Cegolon L., Larese Filon F. Persistence of Symptoms 15 Months since COVID-19 Diagnosis: Prevalence, Risk Factors and Residual Work Ability. Life. 2022;13:97. doi: 10.3390/life13010097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13010097</ArticleId><ArticleId IdType="pmc">PMC9862952</ArticleId><ArticleId IdType="pubmed">36676046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Magnano G., Negro C., Larese Filon F., ORCHESTRA Working Group SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020&#x2013;31 January 2023. Viruses. 2023;15:1551. doi: 10.3390/v15071551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15071551</ArticleId><ArticleId IdType="pmc">PMC10384331</ArticleId><ArticleId IdType="pubmed">37515237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Ronchese F., Ricci F., Negro C., Larese-Filon F. SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020&#x2013;7 February 2022: Occupational Risk and the Impact of the Omicron Variant. Viruses. 2022;28:1663. doi: 10.3390/v14081663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081663</ArticleId><ArticleId IdType="pmc">PMC9413002</ArticleId><ArticleId IdType="pubmed">36016284</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Excess Mortality Collaborators Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020&#x2013;2021. Lancet. 2022;399:1513&#x2013;1536. doi: 10.1016/S0140-6736(21)02796-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuppuswamy A. The fatigue conundrum. Brain. 2017;140:2240&#x2013;2245. doi: 10.1093/brain/awx153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx153</ArticleId><ArticleId IdType="pmc">PMC5806506</ArticleId><ArticleId IdType="pubmed">28899013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D., Crawley E., Hautvast J., Katz B.Z., Knoop H., Little P., Taylor R., et al. Long COVID and Post-infective Fatigue Syndrome: A Review. Open Forum Infect. Dis. 2021;8:ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges do Nascimento I.J., von Groote T.C., O&#x2019;Mathuna D.P., Abdulazeem H.M., Henderson C., Jayarajah U., Weerasekara I., Poklepovic Pericic T., Klapproth H.E., Puljak L., et al. Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARSCoV-2) infection in humans: A systematic review and series of meta-analyses. PLoS ONE. 2020;15:e0239235. doi: 10.1371/journal.pone.0239235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239235</ArticleId><ArticleId IdType="pmc">PMC7498028</ArticleId><ArticleId IdType="pubmed">32941548</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdswoth L., Jawad N. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz B.Z., Collin S.M., Murphy G., Katz B.Z., Collin S.M., Murphy G., Moss-Morris R., Wyller V.B., Wensaas K.A., Hautvast J.L., et al. The international Collaborative on Fatigue Following Infection (COFFI) Fatigue. 2018;6:106&#x2013;121. doi: 10.1080/21641846.2018.1426086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2018.1426086</ArticleId><ArticleId IdType="pmc">PMC6333416</ArticleId><ArticleId IdType="pubmed">30666281</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A., International Chronic Fatigue Syndrome Study Group The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 1994;121:953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Piraino B., Vollmer-Conna U., Lloyd A.R. Genetic associations of fatigue and other symptom domains of the acute sickness response to infection. Brain Behav. Immun. 2012;26:552&#x2013;558. doi: 10.1016/j.bbi.2011.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.12.009</ArticleId><ArticleId IdType="pmc">PMC7127134</ArticleId><ArticleId IdType="pubmed">22227623</ArticleId></ArticleIdList></Reference><Reference><Citation>Cvejic E., Li H., Hickie I.B., Wakefield D., Lloyd A.R., Vollmer-Conna U. Contribution of individual psychological and psychosocial factors to symptom severity and time-to-recovery after naturally occurring acute infective illness: The Dubbo Infection Outcomes Study (DIOS) Brain Behav. Immun. 2019;82:76&#x2013;83. doi: 10.1016/j.bbi.2019.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.07.034</ArticleId><ArticleId IdType="pubmed">31376496</ArticleId></ArticleIdList></Reference><Reference><Citation>Theorell T., Blomkvist V., Lindh G., Eveng&#xe5;rd B. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): An examination of CFS patients and subjects with a nonspecific life crisis. Psychosom. Med. 1999;61:304&#x2013;310. doi: 10.1097/00006842-199905000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-199905000-00009</ArticleId><ArticleId IdType="pubmed">10367610</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson M.L., Bruck D. Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: A review. J. Clin. Sleep. Med. 2012;8:719&#x2013;728. doi: 10.5664/jcsm.2276.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.2276</ArticleId><ArticleId IdType="pmc">PMC3501671</ArticleId><ArticleId IdType="pubmed">23243408</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.J., Bahl J.S., Buckley J.D., Thomson R.L., Davison K. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis. Medicine. 2019;98:e17600. doi: 10.1097/MD.0000000000017600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000017600</ArticleId><ArticleId IdType="pmc">PMC6824690</ArticleId><ArticleId IdType="pubmed">31651868</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos A.S., Cleare A.J. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat. Rev. Endocrinol. 2011;8:22&#x2013;32. doi: 10.1038/nrendo.2011.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2011.153</ArticleId><ArticleId IdType="pubmed">21946893</ArticleId></ArticleIdList></Reference><Reference><Citation>Afari N., Buchwald D. Chronic fatigue syndrome: A review. Am. J. Psychiatry. 2003;160:221&#x2013;236. doi: 10.1176/appi.ajp.160.2.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.160.2.221</ArticleId><ArticleId IdType="pubmed">12562565</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntley C.C., Patel K., Mobeen F., Armitage M.N., Pye A., Knight C.B., Mostafa A., Kershaw M., Mughal A.Z., McKemey E., et al. Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: A systematic review and meta-analysis. ERJ Open Res. 2022;8:00056&#x2013;2022. doi: 10.1183/23120541.00056-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00056-2022</ArticleId><ArticleId IdType="pmc">PMC9035766</ArticleId><ArticleId IdType="pubmed">35642193</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney O.J., McEvoy N.L., McElvaney O.F., Carroll T.P., Murphy M.P., Dunlea D.M., N&#xed; Choile&#xe1;in O., Clarke J., O&#x2019;Connor E., Hogan G., et al. Characterization of the inflammatory response to severe COVID-19 illness. Am. J. Respir. Crit. Care Med. 2020;202:812&#x2013;821. doi: 10.1164/rccm.202005-1583OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-1583OC</ArticleId><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., Li Y., Cao Y., Gu J., Wu H., et al. Six-month follow-up chest CT findings after severe covid-19 pneumonia. Radiology. 2021;299:E177&#x2013;E186. doi: 10.1148/radiol.2021203153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett B.K., Goldstein D., Chen M., Davenport T.A., Vollmer-Conna U., Scott E.M., Hickie I.B., Lloyd A.R. Characterization of fatigue states in medicine and psychiatry by structured interview. Psychosom. Med. 2014;76:379&#x2013;388. doi: 10.1097/PSY.0000000000000061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000061</ArticleId><ArticleId IdType="pubmed">25076512</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Pol R., Simonetti O., Larese Filon F., Luzzati R. Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk C OVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life. Pharmaceuticals. 2023;16:721. doi: 10.3390/ph16050721.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph16050721</ArticleId><ArticleId IdType="pmc">PMC10221734</ArticleId><ArticleId IdType="pubmed">37242504</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Government  NERVTAG: Update Note on B.1.1.7 Severity, 11 February 2021.  [(accessed on 23 October 2023)]; Available online:  https://www.gov.uk/government/publications/nervtag-update-note-on-b117-severity-11-february-2021.</Citation></Reference><Reference><Citation>Relan P., Motaze N.V., Kothari K., Askie L., Le Polain O., Van Kerkhove M.D., Diaz J., Tirupakuzhi Vijayaraghavan B.K. Severity and Outcomes of Omicron Variant of SARS-CoV-2 Compared to Delta Variant and Severity of Omicron Sublineages: A Systematic Review and Metanalysis. BMJ Glob. Health. 2023;8:e012328. doi: 10.1136/bmjgh-2023-012328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-012328</ArticleId><ArticleId IdType="pmc">PMC10347449</ArticleId><ArticleId IdType="pubmed">37419502</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen R.H., Ng D.G., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20.. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L., Mastrangelo G., Emanuelli E., Camerotto R., Spinato G., Frezza D. Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial. Pharmaceutics. 2022;14:2502. doi: 10.3390/pharmaceutics14112502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14112502</ArticleId><ArticleId IdType="pmc">PMC9696981</ArticleId><ArticleId IdType="pubmed">36432693</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso P., Negro C., Cegolon L., Larese Filon F. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy) Viruses. 2022;14:336. doi: 10.3390/v14020336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020336</ArticleId><ArticleId IdType="pmc">PMC8875653</ArticleId><ArticleId IdType="pubmed">35215930</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyassat D., El-Khateebn M., Dahbour A., Shunnaq S., Naji D., Bani Ata E., Abujbara M., Khawaja N., Batieha A., Ajlouni K. Post-COVID-19 syndrome among healthcare workers in Jordan. EMHJ. 2023;29:247&#x2013;253. doi: 10.26719/emhj.23.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.26719/emhj.23.029</ArticleId><ArticleId IdType="pubmed">37246435</ArticleId></ArticleIdList></Reference><Reference><Citation>Twitchell D.K., Christensen M.B., Hackett G., Morgentaler A., Saad F., Pastuszak A.W. Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic Review. Androg. Clin. Res. Ther. 2022;3:41&#x2013;53. doi: 10.1089/andro.2022.0006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/andro.2022.0006</ArticleId><ArticleId IdType="pmc">PMC9527649</ArticleId><ArticleId IdType="pubmed">36199281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>